Novo A/S as of Dec. 31, 2016
Portfolio Holdings for Novo A/S
Novo A/S holds 22 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Inogen (INGN) | 22.7 | $238M | 3.5M | 67.17 | |
| Vanguard Total Stock Market ETF (VTI) | 17.8 | $187M | 1.6M | 115.32 | |
| Colucid Pharmaceuticals | 10.9 | $115M | 3.2M | 36.40 | |
| Vanguard European ETF (VGK) | 9.6 | $101M | 2.1M | 47.94 | |
| Reata Pharmaceuticals Inc Cl A | 7.0 | $74M | 3.4M | 21.83 | |
| Irhythm Technologies (IRTC) | 5.8 | $61M | 2.0M | 30.00 | |
| Corvus Pharmaceuticals (CRVS) | 4.4 | $46M | 3.2M | 14.30 | |
| Acceleron Pharma | 3.0 | $32M | 1.2M | 25.52 | |
| Ra Pharmaceuticals | 2.9 | $31M | 2.0M | 15.19 | |
| Merus N V (MRUS) | 2.8 | $30M | 1.4M | 21.11 | |
| Spectranetics Corporation | 2.8 | $29M | 1.2M | 24.50 | |
| Flexion Therapeutics | 2.5 | $27M | 1.4M | 19.02 | |
| Kalvista Pharmaceuticals (KALV) | 1.9 | $21M | 2.9M | 7.07 | |
| Apollo Endosurgery | 1.7 | $18M | 1.5M | 12.16 | |
| Nabriva Therapeutics | 1.3 | $14M | 2.3M | 5.96 | |
| Invuity | 0.7 | $7.6M | 1.3M | 5.75 | |
| Dermira | 0.6 | $6.6M | 217k | 30.33 | |
| Wright Medical Group Rtsn V | 0.6 | $6.1M | 4.6M | 1.32 | |
| Crispr Therapeutics (CRSP) | 0.4 | $4.5M | 223k | 20.26 | |
| Htg Molecular Diagnostics | 0.3 | $2.9M | 1.3M | 2.24 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $982k | 128k | 7.70 | |
| Opko Health (OPK) | 0.0 | $2.0k | 259.00 | 7.72 |
